Wiki source code of Methodology
Version 23.1 by manuelmenendez on 2025/02/15 12:55
Hide last authors
author | version | line-number | content |
---|---|---|---|
![]() |
22.1 | 1 | **Neurodiagnoses AI** is an open-source, AI-driven framework designed to enhance the diagnosis and prognosis of central nervous system (CNS) disorders. Building upon the Florey Dementia Index (FDI) methodology, it now encompasses a broader spectrum of neurological conditions. The system integrates multimodal data sources—including EEG, neuroimaging, biomarkers, and genetics—and employs machine learning models to deliver explainable, real-time diagnostic insights. A key feature of this framework is the incorporation of the **Generalized Neuro Biomarker Ontology Categorization (Neuromarker)**, which standardizes biomarker classification across all neurodegenerative diseases, facilitating cross-disease AI training. |
![]() |
1.1 | 2 | |
![]() |
22.1 | 3 | **Neuromarker: Generalized Biomarker Ontology** |
![]() |
1.1 | 4 | |
![]() |
22.1 | 5 | Neuromarker extends the Common Alzheimer’s Disease Research Ontology (CADRO) into a comprehensive biomarker categorization framework applicable to all neurodegenerative diseases (NDDs). This ontology enables standardized classification, AI-based feature extraction, and seamless multimodal data integration. |
![]() |
1.1 | 6 | |
![]() |
22.1 | 7 | **Core Biomarker Categories** |
![]() |
19.1 | 8 | |
![]() |
22.1 | 9 | Within the Neurodiagnoses AI framework, biomarkers are categorized as follows: |
![]() |
19.1 | 10 | |
![]() |
20.1 | 11 | |=**Category**|=**Description** |
12 | |**Molecular Biomarkers**|Omics-based markers (genomic, transcriptomic, proteomic, metabolomic, lipidomic) | ||
13 | |**Neuroimaging Biomarkers**|Structural (MRI, CT), Functional (fMRI, PET), Molecular Imaging (tau, amyloid, α-synuclein) | ||
![]() |
23.1 | 14 | |**Fluid Biomarkers**|CSF, plasma, blood-based markers for tau, amyloid, α-synuclein, TDP-43, GFAP, NfL, autoantiboides |
![]() |
20.1 | 15 | |**Neurophysiological Biomarkers**|EEG, MEG, evoked potentials (ERP), sleep-related markers |
16 | |**Digital Biomarkers**|Gait analysis, cognitive/speech biomarkers, wearables data, EHR-based markers | ||
17 | |**Clinical Phenotypic Markers**|Standardized clinical scores (MMSE, MoCA, CDR, UPDRS, ALSFRS, UHDRS) | ||
18 | |**Genetic Biomarkers**|Risk alleles (APOE, LRRK2, MAPT, C9orf72, PRNP) and polygenic risk scores | ||
19 | |**Environmental & Lifestyle Factors**|Toxins, infections, diet, microbiome, comorbidities | ||
![]() |
19.1 | 20 | |
![]() |
22.1 | 21 | **Integrating External Databases into Neurodiagnoses** |
![]() |
19.1 | 22 | |
![]() |
22.1 | 23 | To enhance diagnostic precision, Neurodiagnoses AI incorporates data from multiple biomedical and neurological research databases. Researchers can integrate external datasets by following these steps: |
![]() |
1.1 | 24 | |
![]() |
22.1 | 25 | 1. ((( |
26 | **Register for Access** | ||
![]() |
12.2 | 27 | |
![]() |
22.1 | 28 | * Each external database requires individual registration and access approval. |
29 | * Ensure compliance with ethical approvals and data usage agreements before integrating datasets into Neurodiagnoses. | ||
30 | * Some repositories may require a Data Usage Agreement (DUA) for sensitive medical data. | ||
31 | ))) | ||
32 | 1. ((( | ||
33 | **Download & Prepare Data** | ||
![]() |
12.2 | 34 | |
![]() |
22.1 | 35 | * Download datasets while adhering to database usage policies. |
36 | * ((( | ||
37 | Ensure files meet Neurodiagnoses format requirements: | ||
![]() |
12.2 | 38 | |
![]() |
20.1 | 39 | |=**Data Type**|=**Accepted Formats** |
40 | |**Tabular Data**|.csv, .tsv | ||
41 | |**Neuroimaging**|.nii, .dcm | ||
42 | |**Genomic Data**|.fasta, .vcf | ||
43 | |**Clinical Metadata**|.json, .xml | ||
![]() |
22.1 | 44 | ))) |
45 | * ((( | ||
46 | **Mandatory Fields for Integration**: | ||
![]() |
12.2 | 47 | |
![]() |
22.1 | 48 | * Subject ID: Unique patient identifier |
49 | * Diagnosis: Standardized disease classification | ||
50 | * Biomarkers: CSF, plasma, or imaging biomarkers | ||
51 | * Genetic Data: Whole-genome or exome sequencing | ||
52 | * Neuroimaging Metadata: MRI/PET acquisition parameters | ||
53 | ))) | ||
54 | ))) | ||
55 | 1. ((( | ||
56 | **Upload Data to Neurodiagnoses** | ||
![]() |
12.2 | 57 | |
![]() |
22.1 | 58 | * ((( |
59 | **Option 1: Upload to EBRAINS Bucket** | ||
![]() |
12.2 | 60 | |
![]() |
22.1 | 61 | * Location: EBRAINS Neurodiagnoses Bucket |
62 | * Ensure correct metadata tagging before submission. | ||
63 | ))) | ||
64 | * ((( | ||
65 | **Option 2: Contribute via GitHub Repository** | ||
![]() |
12.2 | 66 | |
![]() |
22.1 | 67 | * Location: GitHub Data Repository |
68 | * Create a new folder under /data/ and include a dataset description. | ||
69 | * For large datasets, contact project administrators before uploading. | ||
70 | ))) | ||
71 | ))) | ||
72 | 1. ((( | ||
73 | **Integrate Data into AI Models** | ||
![]() |
12.2 | 74 | |
![]() |
22.1 | 75 | * Open Jupyter Notebooks on EBRAINS to run preprocessing scripts. |
76 | * Standardize neuroimaging and biomarker formats using harmonization tools. | ||
77 | * Utilize machine learning models to handle missing data and feature extraction. | ||
78 | * Train AI models with newly integrated patient cohorts. | ||
![]() |
12.2 | 79 | |
![]() |
20.1 | 80 | **Reference**: See docs/data_processing.md for detailed instructions. |
![]() |
22.1 | 81 | ))) |
![]() |
12.2 | 82 | |
![]() |
22.1 | 83 | **AI-Driven Biomarker Categorization** |
![]() |
12.2 | 84 | |
![]() |
22.1 | 85 | Neurodiagnoses employs advanced AI models for biomarker classification: |
![]() |
12.2 | 86 | |
![]() |
20.1 | 87 | |=**Model Type**|=**Application** |
88 | |**Graph Neural Networks (GNNs)**|Identify shared biomarker pathways across diseases | ||
89 | |**Contrastive Learning**|Distinguish overlapping vs. unique biomarkers | ||
90 | |**Multimodal Transformer Models**|Integrate imaging, omics, and clinical data | ||
![]() |
1.1 | 91 | |
![]() |
22.1 | 92 | **Collaboration & Partnerships** |
![]() |
1.1 | 93 | |
![]() |
22.1 | 94 | Neurodiagnoses actively seeks partnerships with data providers to: |
![]() |
21.1 | 95 | |
![]() |
22.1 | 96 | * Enable API-based data integration for real-time processing. |
97 | * Co-develop harmonized AI-ready datasets with standardized annotations. | ||
98 | * Secure funding opportunities through joint grant applications. | ||
![]() |
6.1 | 99 | |
![]() |
20.1 | 100 | **Interested in Partnering?** |
![]() |
1.1 | 101 | |
![]() |
22.1 | 102 | If you represent a research consortium or database provider, reach out to explore data-sharing agreements. |
![]() |
1.1 | 103 | |
![]() |
22.1 | 104 | **Contact**: [[info@neurodiagnoses.com>>mailto:info@neurodiagnoses.com]] |
![]() |
1.1 | 105 | |
![]() |
22.1 | 106 |